人参汤加味配合西医常规疗法治疗慢性充血性心力衰竭临床研究

目的 评价人参汤加味配合西医常规疗法治疗慢性充血性心力衰竭的疗效.方法 将符合入选标准的慢性充血性心力衰竭患者75例,采用随机数字表法分为治疗组38例和对照组37例.对照组采用西医常规疗法治疗,治疗组在对照组基础上配合人参汤加味治疗.2组均治疗2周.采用ELISA法测定血清BNP水平,观察2组治疗前后心功能分级及中医证候评分变化,评价临床疗效.结果 治疗组心功能分级疗效总有效率为92.1%(35/38)、对照组为73.0%(27/37),2组比较差异有统计学意义(χ2=4.343,P<0.05).治疗组中医证候疗效总有效率为94.7%(36/38)、对照组为73.0%(27/37),2组比较差异有统计学意义(χ2=4.649,P<0.05).治疗后,治疗组血清BNP水平[(1477.1±316.7)pg/ml比(2256.9±521.3)pg/ml,t=7.853]低于对照组(P<0.01).结论 人参汤加味配合西医常规疗法可明显降低慢性充血性心力衰竭血清BNP水平,减轻症状,改善患者的心功能.

Clinical study of modified Renshen decoction plus routine western medicine on patients of chronic congestive heart failure

Objective To evaluate the effect of modified Renshen decoction plus routine western medicine on chronic congestive heart failure. Methods The selected 75 candidate patients were divided into control group with 37 patients and treatment group with 38 patients. The patients of control group received routine western medicine and treatment group received modified Renshen decoction plus routine western medicine. After 2 weeks of treatment, the effect of both group were evaluated with indictors of clinical heart function, BNP and traditional Chinese syndrome. Results There were significantly statistical difference, of total effective ratio of clinical heart function (χ2=4.343, P<0.05)between the treatment group (92.1%,35/38)and control group (73.0%, 27/37), and of total effective ratio of traditional Chinese syndrome (χ2=4.649, P<0.05) between the treatment group (94.7%, 36/38) and control group (73.0%, 27/37). The BNP levels of both group decreased significantly (P<0.05), and the significant statistical difference between two groups was also observed 1477.1 ± 316.7 pg/ml vs. 2256.9 ± 521.3 pg/ml; t=7.853, P<0.01). Conclusions The Modified Renshen decoction plus routine western medicine could improve chronic congestive heart failure patients' the heart function, reduce BNP and attenuate the symptoms.